Breaking News
Get 45% Off 0
🔎 How to spot overhyped stocks (like these) before they drop
Read more

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Fluor (FLR) Q4 Earnings & Revenues Lag Estimates, Stock Down By Zacks Investment Research - Feb 28, 2021

Fluor Corporation (NYSE:FLR) FLR reported fourth-quarter results with earnings and revenues missing the Zacks Consensus Estimate. The top line missed the Zacks Consensus Estimate for the second...

UniQure (QURE) Reports Q4 Loss, Lags Revenue Estimates By Zacks Investment Research - Feb 28, 2021

UniQure (QURE) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to loss of $0.97 per share a year ago. These figures are adjusted...

Can Cathie Wood Send Space ETFs to the Moon? By Zacks Investment Research - Feb 28, 2021

In this episode of ETF Spotlight, I speak with Andrew Chanin, CEO of ProcureAM, and Micah Walter-Range, founder of Space Investment Services, about investing in space. NASA’s fastest and most...

Stocks Stay Positive in February Despite Rising Rates By Zacks Investment Research - Feb 26, 2021

Tech recovered some of its recent losses on Friday, but the major indices still dropped for the week as the market just can’t relax while rates are on the rise. Nevertheless, stocks were...

Northwest Natural (NWN) Q4 Earnings Meet Estimates By Zacks Investment Research - Feb 26, 2021

Northwest Natural (NWN) came out with quarterly earnings of $1.50 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.26 per share a year ago. These figures are...

LHC Group (LHCG) Tops Q4 Earnings Estimates By Zacks Investment Research - Feb 26, 2021

LHC Group (NASDAQ:LHCG) came out with quarterly earnings of $1.40 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.15 per share a year ago. These...

Top 5 Corporate Bigwigs Flying High in a Volatile February By Zacks Investment Research - Feb 26, 2021

February is turning out to be extremely volatile with just a day of trading left. In the first two weeks of this month, Wall Street's northbound journey continued smoothly. However, the problem...

Time to Buy Giant Tech Stocks at a Discount? By Zacks Investment Research - Feb 26, 2021 1

The Nasdaq closed at all-time highs only two weeks ago, as Wall Street celebrated stronger-than-expected earnings results and the likelihood of more government spending. But things changed quickly....

Inflation Perfect Storm: The Fed's Dual Conundrum By Zacks Investment Research - Feb 26, 2021

(1:30) - Centrifugal Force: Markets Coil Then Jump(9:20) - Big Move In Bonds: Financial Plumbing Pressures(15:10) - Richly-Valued Growth Stocks Overdue to Correct(20:40) - GameStop (NYSE:GME) Stock...

Should You Dump Tesla But Buy EV ETFs Now? By Zacks Investment Research - Feb 26, 2021

One of the hottest tickers of Wall Street that has jumped more than 1000% in the past two years – Tesla (NASDAQ:TSLA) (TSLA) – will likely stage a losing streak in the near term on rising...

Beyond Meat Prepares for a High-Growth Phase By Zacks Investment Research - Feb 26, 2021

I’ve been a Beyond Meat (NASDAQ:BYND) BYND fan for a while now, despite the crazy way the pandemic has moved its shares around. Somehow, I really like the sound of “revolutionary...

Intellia (NTLA) Miss Earnings & Revenues Estimates in Q4 By Zacks Investment Research - Feb 26, 2021

Intellia Therapeutics (NASDAQ:NTLA), Inc. NTLA is a clinical-stage company with focus on developing gene editing therapies, especially for rare diseases. The company earns revenues from its...

Humana (HUM), Mercy Tie Up to Extend Telehealth Services By Zacks Investment Research - Feb 25, 2021

Humana Inc (NYSE:HUM). HUM recently inked a deal with Missouri-based Mercy to enhance virtual healthcare for patients. This is an extension to offer holistic medical care to its Humana Medicare...

Continue with Apple
Continue with Google
or
Sign up with Email